{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T02:28:39Z","timestamp":1777775319341,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00207,868"],"award-info":[{"award-number":["RS-2023-00207,868"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.biomaterials.2023.122233","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T17:29:06Z","timestamp":1687973346000},"page":"122233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Immunosuppressive nanoparticles containing recombinant PD-L1 and methotrexate alleviate multi-organ inflammation"],"prefix":"10.1016","volume":"301","author":[{"given":"Eun-Koung","family":"An","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hae-Bin","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"So-Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee-Yun","family":"Eom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juyoung","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0480-1804","authenticated-orcid":false,"given":"Minseok","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Yeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter Chang-Whan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4216-8111","authenticated-orcid":false,"given":"Jun-O","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.biomaterials.2023.122233_bib1","first-page":"585","volume":"17","author":"Szekanecz","year":"2021","journal-title":"Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases"},{"issue":"7","key":"10.1016\/j.biomaterials.2023.122233_bib2","first-page":"809","article-title":"Not-so-opposite ends of the spectrum: CD8+ T cell dysfunction across chronic infection","volume":"22","author":"Collier","year":"2021","journal-title":"Cancer and autoimmunity"},{"key":"10.1016\/j.biomaterials.2023.122233_bib3","first-page":"75","article-title":"Manipulating antigen presentation for antigen-specific immunotherapy of autoimmune","volume":"70","author":"Streeter","year":"2021","journal-title":"Diseases"},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122233_bib4","volume":"21","author":"Khaitan","year":"2022","journal-title":"Autoimmunity in vitiligo: therapeutic implications and opportunities"},{"issue":"9894","key":"10.1016\/j.biomaterials.2023.122233_bib5","first-page":"819","volume":"382","author":"Wahren-Herlenius","year":"2013","journal-title":"Immunopathogenic mechanisms of systemic autoimmune disease"},{"issue":"5","key":"10.1016\/j.biomaterials.2023.122233_bib6","first-page":"811","volume":"87","author":"Kouskoff","year":"1996","journal-title":"Organ-specific disease provoked by systemic autoimmunity"},{"issue":"7061","key":"10.1016\/j.biomaterials.2023.122233_bib7","first-page":"1032","volume":"437","author":"Calvano","year":"2005","journal-title":"A network-based analysis of systemic inflammation in humans"},{"key":"10.1016\/j.biomaterials.2023.122233_bib8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.bbi.2020.07.017","article-title":"Discrimination and systemic inflammation: A critical review and synthesis","volume":"89","author":"Cuevas","year":"2020","journal-title":"Behavior immunity"},{"issue":"4","key":"10.1016\/j.biomaterials.2023.122233_bib9","first-page":"1081","volume":"9","author":"Jain","year":"2020","journal-title":"Sarcoidosis: causes, diagnosis, clinical features, and treatments"},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122233_bib10","first-page":"642","article-title":"Anti-inflammatory drug resistance selects putative cancer stem cells in a cellular model for genetically predisposed colon cancer","volume":"15","author":"Telang","year":"2018","journal-title":"Oncol. Lett."},{"issue":"17\u201318","key":"10.1016\/j.biomaterials.2023.122233_bib11","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.drudis.2012.05.011","article-title":"Glucocorticoid-resistant asthma and novel anti-inflammatory drugs","volume":"17","author":"Keenan","year":"2012","journal-title":"Drug Discov. Today"},{"issue":"9","key":"10.1016\/j.biomaterials.2023.122233_bib12","first-page":"1069","article-title":"Fundamental mechanisms of immune checkpoint blockade TherapyFundamental mechanisms of immune checkpoint blockade","volume":"8","author":"Wei","year":"2018","journal-title":"Therapy"},{"key":"10.1016\/j.biomaterials.2023.122233_bib13","first-page":"29","volume":"62","author":"Hargadon","year":"2018","journal-title":"Immune checkpoint blockade therapy for cancer: an overview of FDA-approved immune checkpoint inhibitors"},{"issue":"5","key":"10.1016\/j.biomaterials.2023.122233_bib14","first-page":"1111","article-title":"immunotherapeutics, PD-1 and PD-L1 in cancer immunotherapy","volume":"15","author":"Jiang","year":"2019","journal-title":"clinical implications and future considerations"},{"issue":"4","key":"10.1016\/j.biomaterials.2023.122233_bib15","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/s41551-019-0360-0","article-title":"Depletion of PD-1-positive cells ameliorates autoimmune disease","volume":"3","author":"Zhao","year":"2019","journal-title":"Nature biomedical engineering"},{"issue":"26","key":"10.1016\/j.biomaterials.2023.122233_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201907692","article-title":"Engineered PD\u2010L1\u2010expressing platelets reverse new\u2010onset type 1 diabetes","volume":"32","author":"Zhang","year":"2020","journal-title":"Adv. Mater."},{"issue":"5","key":"10.1016\/j.biomaterials.2023.122233_bib17","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000480641","article-title":"The systemic activation of programmed death 1-PD-L1 axis protects systemic lupus erythematosus model from nephritis","volume":"46","author":"Liao","year":"2017","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.biomaterials.2023.122233_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cellimm.2016.09.009","article-title":"PD-1\/PD-L and autoimmunity: a growing relationship","volume":"310","author":"Zamani","year":"2016","journal-title":"Cell. Immunol."},{"issue":"111","key":"10.1016\/j.biomaterials.2023.122233_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003130","article-title":"The PDL1-PD1 axis converts human TH1 cells into regulatory T cells","volume":"3","author":"Amarnath","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biomaterials.2023.122233_bib20","volume":"285","author":"Hwang","year":"2022","journal-title":"Recombinant programmed cell death protein 1 functions as an immune check point blockade and enhances anti-cancer immunity"},{"issue":"5","key":"10.1016\/j.biomaterials.2023.122233_bib21","first-page":"8472","article-title":"Escherichia coli mimetic gold nanorod-mediated photo-and immunotherapy for treating","volume":"16","author":"Hwang","year":"2022","journal-title":"Cancer and Its Metastasis"},{"issue":"6092","key":"10.1016\/j.biomaterials.2023.122233_bib22","first-page":"303","volume":"337","author":"Hubbell","year":"2012","journal-title":"Nanomaterials for drug delivery"},{"issue":"3","key":"10.1016\/j.biomaterials.2023.122233_bib23","first-page":"744","article-title":"Chemical modifications and bioconjugate reactions of nanomaterials for sensing, imaging","volume":"43","author":"Biju","year":"2014","journal-title":"drug delivery and therapy"},{"issue":"4","key":"10.1016\/j.biomaterials.2023.122233_bib24","first-page":"1690","volume":"5","author":"Srinivasan","year":"2015","journal-title":"Multifunctional nanomaterials and their applications in drug delivery and cancer therapy"},{"issue":"7","key":"10.1016\/j.biomaterials.2023.122233_bib25","volume":"9","author":"Hwang","year":"2021","journal-title":"Escherichia coli adhesin protein-conjugated thermal responsive hybrid nanoparticles for photothermal and immunotherapy against cancer and its metastasis"},{"key":"10.1016\/j.biomaterials.2023.122233_bib27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jaut.2012.07.009","article-title":"Interleukin-6 induces the generation of IL-10-producing Tr1 cells and suppresses autoimmune tissue inflammation","volume":"40","author":"Jin","year":"2013","journal-title":"J. Autoimmun."},{"issue":"7","key":"10.1016\/j.biomaterials.2023.122233_bib28","volume":"7","author":"DiDomenico","year":"2018","journal-title":"The immune checkpoint protein PD-L1 induces and maintains regulatory T cells in glioblastoma"},{"issue":"18","key":"10.1016\/j.biomaterials.2023.122233_bib29","volume":"96","author":"Wang","year":"2017","journal-title":"Prognostic significance of PD-L1 in solid tumor: an updated meta-analysis"},{"issue":"4","key":"10.1016\/j.biomaterials.2023.122233_bib30","first-page":"5058","volume":"9","author":"Xiang","year":"2018","journal-title":"Prognostic value of PD\u2013L1 expression in patients with primary solid tumors"},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122233_bib31","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12964-021-00816-w","article-title":"Extracellular vesicle PD-L1 in reshaping tumor immune microenvironment: biological function and potential therapy strategies","volume":"20","author":"Liu","year":"2022","journal-title":"Cell Commun. Signal."},{"issue":"11","key":"10.1016\/j.biomaterials.2023.122233_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/cells10113247","article-title":"The importance of exosomal PD-L1 in cancer progression and its potential as a therapeutic target","volume":"10","author":"Ye","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.biomaterials.2023.122233_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.569219","article-title":"Exosomal PD-L1: new insights into tumor immune escape mechanisms and therapeutic strategies","volume":"8","author":"Zhou","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"7718","key":"10.1016\/j.biomaterials.2023.122233_bib34","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2023.122233_bib35","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.3389\/fimmu.2020.01710","article-title":"PD-L1 is expressed and promotes the expansion of regulatory T cells in acute myeloid leukemia","volume":"11","author":"Dong","year":"2020","journal-title":"Front. Immunol."},{"issue":"13","key":"10.1016\/j.biomaterials.2023.122233_bib36","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1084\/jem.20090847","article-title":"PD-L1 regulates the development, maintenance, and function of induced regulatory T cells","volume":"206","author":"Francisco","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biomaterials.2023.122233_bib37","article-title":"Design, Review of hybrid PLGA nanoparticles","volume":"193","author":"Ghitman","year":"2020","journal-title":"Future of smart drug delivery and theranostics medicine"},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122233_bib38","first-page":"1","article-title":"ipid-based surface engineering of PLGA nanoparticles for drug and gene delivery applications","volume":"20","author":"Bose","year":"2016","journal-title":"L"},{"issue":"9","key":"10.1016\/j.biomaterials.2023.122233_bib39","first-page":"1003","volume":"5","author":"Torchilin","year":"2008","journal-title":"Antibody-modified liposomes for cancer chemotherapy"},{"key":"10.1016\/j.biomaterials.2023.122233_bib40","article-title":"Advances in liposomal drug delivery to cancer: An overview","volume":"56","author":"Saraf","year":"2020","journal-title":"technology"},{"issue":"12","key":"10.1016\/j.biomaterials.2023.122233_bib41","first-page":"3939","volume":"4","author":"Jain","year":"2018","journal-title":"Engineering, Protein nanoparticles: promising platforms for drug delivery applications"},{"issue":"10","key":"10.1016\/j.biomaterials.2023.122233_bib42","first-page":"3574","volume":"47","author":"Spicer","year":"2018","journal-title":"Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications"},{"issue":"4","key":"10.1016\/j.biomaterials.2023.122233_bib43","first-page":"632","volume":"71","author":"Horwitz","year":"2019","journal-title":"Rheumatology, Suppression of Murine Lupus by CD 4+ and CD 8+ Treg Cells Induced by T Cell\u2013Targeted Nanoparticles Loaded With Interleukin\u20102 and Transforming Growth Factor \u03b2"},{"key":"10.1016\/j.biomaterials.2023.122233_bib44","first-page":"84","volume":"281","author":"Ou","year":"2018","journal-title":"Regulatory T cell-targeted hybrid nanoparticles combined with immuno-checkpoint blockage for cancer immunotherapy"},{"issue":"3","key":"10.1016\/j.biomaterials.2023.122233_bib45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nri.2017.108","article-title":"The diverse functions of the PD1 inhibitory pathway","volume":"18","author":"Sharpe","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.biomaterials.2023.122233_bib46","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/gutjnl-2014-307311","article-title":"Protective effects of Fc-fused PD-L1 on two different animal models of colitis","volume":"64","author":"Song","year":"2015","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122233_bib47","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2019.1709262","article-title":"Exosomal PD-L1 functions as an immunosuppressant to promote wound healing","volume":"9","author":"Su","year":"2019","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.biomaterials.2023.122233_bib48","series-title":"Seminars in Immunopathology","first-page":"475","article-title":"Harnessing the liver to induce antigen-specific immune tolerance","author":"Gottwick","year":"2022"},{"key":"10.1016\/j.biomaterials.2023.122233_bib49","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jconrel.2021.01.013","article-title":"PEGylation enables subcutaneously administered nanoparticles to induce antigen-specific immune tolerance","volume":"331","author":"Li","year":"2021","journal-title":"J. Contr. Release"},{"issue":"4","key":"10.1016\/j.biomaterials.2023.122233_bib50","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1021\/acsnano.9b01444","article-title":"Use of polymeric nanoparticle platform targeting the liver to induce treg-mediated antigen-specific immune tolerance in a pulmonary allergen sensitization model","volume":"13","author":"Liu","year":"2019","journal-title":"ACS Nano"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961223002417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961223002417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:05:53Z","timestamp":1777485953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961223002417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":49,"alternative-id":["S0142961223002417"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2023.122233","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunosuppressive nanoparticles containing recombinant PD-L1 and methotrexate alleviate multi-organ inflammation","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2023.122233","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122233"}}